Investors wary of Teva-Mylan merger By: MarketWatch April 21, 2015 at 12:36 PM EDT Investors were wary of Teva Pharmaceuticals’ plan to purchase Mylan N.V., and failed to drive up Mylan share to Teva’s bid price. Read More >> Related Stocks: Macy's Mylan Perrigo Teva Pharmaceutical Industries ADR